Skip directly to content

Publications 2012

2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992

TAG Update
The December 2012 issue:

Tuberculosis Research and Development: 2012 Report on Tuberculosis Research Funding Trends, 2005–2011
November 14, 2012 – Now in its seventh year, TAG's Tuberculosis Research and Development: 2012 Report on Tuberculosis Research Funding Trends: 2005–2011 builds on seven years of investment data to report on annual funding trends and gaps among the leading TB R&D donors. The report analyzes current spending levels across six research areas to assess how they compare to the Stop TB Partnership’s Global Plan to Stop TB 2011–2015 R&D funding targets.

TAGline Fall 2012

HIV, Hepatitis C Virus (HCV), and Tuberculosis (TB) Drugs, Diagnostics, Vaccines, and Preventive Technologies in Development
July 22, 2012 – Visit our new website to:

  • Read the report online
  • Download individual chapters as PDFs
  • Browse for specific information by agent

TAGline Spring 2012

HCV Factsheets
April 2012 – These HCV protease inhibitor fact sheets describe how each drug should be used, how likely treatment is to be successful, common side effects, drugs that cannot be used with each HCV protease inhibitor, and information about co-pay assistance and patient assistance programs.

Being Brave: Stories of Children with Drug-Resistant Tuberculosis
March 2012 – When it comes to drug-resistant tuberculosis (DR-TB), the global community is failing to “get it right.” Millions of people around the world suffer from this dangerous, yet treatable, infectious disease. Yet, in over a decade, less than 1% of those with DR-TB have been diagnosed and treated. Children bear a disproportionate burden of this disease, and are far less likely than adults with DR-TB to have access to appropriate care. This collection gives voice to the children from around the world featured in it, and to the thousands more like them who face the challenges of fighting DR-TB every day. It is also a global call to action. These stories invite all of us to join children with DR-TB and their families and caregivers in the struggle for better diagnosis and treatment. It is the first step toward “getting it right” for children with TB.